Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

3 weeks ago

ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed…

Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

3 weeks ago

REDWOOD CITY, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical…

TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years

3 weeks ago

WALTHAM, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) --  TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the…

RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System

3 weeks ago

Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy RenovoRx Estimates Initial Target Market Size…

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

3 weeks ago

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing…

Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting

3 weeks ago

Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the…

LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution

3 weeks ago

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,…

ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024

3 weeks ago

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 05, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated…

Ultrahuman scales to 30% market share as it introduces the world’s first subscription-free Ovulation Tracking

3 weeks ago

Ultrahuman revolutionizes fertility tracking with multi-biomarker-based Ovulation Prediction on the Ring AIR.London, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Ultrahuman, a…

BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data

3 weeks ago

Bio|Verse Navigator can accelerate data exploration and interpretation workflows multifold, reducing time-to-insight for researchers.The application combines advanced BioLizard’s bioinformatics expertise…